Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
5367881
Reference Type
Journal Article
Title
New functional probiotic Lactobacillus sakei probio 65 alleviates atopic symptoms in the mouse
Author(s)
Park, CW; Youn, M; Jung, YM; Kim, H; Jeong, Y; Lee, HK; Kim, HO; Lee, I; Lee, SW; Kang, KH; Park, YH
Year
2008
Is Peer Reviewed?
Yes
Journal
Journal of Medicinal Food
ISSN:
1096-620X
EISSN:
1557-7600
Volume
11
Issue
3
Page Numbers
405-412
Language
English
PMID
18800885
DOI
10.1089/jmf.2007.0144
Web of Science Id
WOS:000259677200002
Abstract
The purpose of this study was to investigate the improvement of allergic dermatitis in chemical allergen-induced mice by Lactobacillus sakei probio 65. L. sakei probio-65 was isolated from kimchi, a traditional Korean fermented food. This strain was resistant to gastric acidity, bile, and several antibiotics and possessed antimicrobial activity against several pathogenic microorganisms. To investigate whether the probiotic activity of L. sakei probio 65 was effective for treating allergic dermatitis, the organism was supplied to mice triggered by allergen (1-chloro-2,4-dinitrobenzene). Mice that received L. sakei probio 65 showed a more rapid recovery compared to control mice, as assessed by visual evaluation of the severity of allergic dermatitis and levels of immunoglobulin (Ig) E and interleukin (IL)-4. L. sakei probio 65 exhibited good probiotic properties in vitro and in mice and was effective in reducing allergen-induced skin inflammation through the regulation of both elevated IgE and IL-4 in sensitized mice.
Keywords
Allergic dermatitis; Immunoglobulin E; Interleukin-4; Lactobacillus sakei probio 65; Probiotics
Tags
PPRTV
•
1,3-Dinitrobenzene 2021
Literature Search June 2021
PubMed
Scopus (July 2021)
WOS
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity